Vivani Medical to Present at Emerging Growth Conference

Vivani Medical, Inc. (NASDAQ: VANI) has announced its participation in the Emerging Growth Conference, scheduled for July 15, 2026. The company will present an update on its business and development activities.

CEO Adam Mendelsohn, Ph.D., is set to deliver the presentation, which will also include a question-and-answer session. Individual and institutional investors, advisors, and analysts are invited to attend the interactive session. Those wishing to submit questions in advance can do so via email to Questions@EmergingGrowth.com. The presentation is scheduled to begin at 4:10 p.m. Eastern Time.

Vivani Medical is developing novel, miniature GLP-1 drug implants designed for once- or twice-yearly administration. The company's proprietary NanoPortal™ platform aims to deliver drug molecules steadily over extended periods, addressing challenges with medication adherence and patient tolerance, particularly for metabolic diseases like obesity and type 2 diabetes.

The company's implants are intended to overcome issues associated with daily or weekly oral and injectable medications, which often lead to tolerability problems and reduced efficacy. Non-adherence affects a significant portion of patients, impacting treatment outcomes. An archived webcast of the presentation will be available on EmergingGrowth.com and the Emerging Growth YouTube channel following the conference.

Further details about Vivani Medical and its product candidates can be found on the company's website at www.vivani.com.